-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ventyx Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q4 2024.
- Ventyx Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $3.07M, a 14.6% decline year-over-year.
- Ventyx Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $13.3M, a 11.3% decline year-over-year.
- Ventyx Biosciences, Inc. annual Nonoperating Income (Expense) for 2024 was $13.3M, a 11.3% decline from 2023.
- Ventyx Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $15M, a 219% increase from 2022.
- Ventyx Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $4.71M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)